指导原则库
CMDE 与 FDA 医疗器械及 CDRH 相关指导文件的历史目录。保留原始标题、发布日期和版本状态,点击官方原文或附件阅读全文。历史收录不计入当日新增;正式文件标签表示发布时的状态,现行版本以官方原文为准。
2,097 条目录记录 · 官方公开目录核对 2026/10/23 · 批量发布通告可能包含多份文件
乙型肝炎病毒e抗原、e抗体检测试剂注册技术审查指导原则(2020年第16号)
乙型肝炎病毒耐药相关的基因突变检测试剂注册技术审查指导原则(2020年第16号)
用于放射治疗的X射线图像引导系统注册技术审查指导原则(2020年 第13号)
半导体激光脱毛机注册技术审查指导原则(2020年第15号)
Premarket Notification (510(k)) Submissions for Electrosurgical Devices for General Surgery: Guidance for Industry and Food and Drug Administration Staff
官方主题:Premarket, 510(k), Clinical - Medical, Good Clinical Practice (GCP), Labeling, General & Plastic Surgery
抗核抗体检测试剂注册技术审查指导原则(2020年第14号)
糖化白蛋白测定试剂注册技术审查指导原则(2020年第14号)
关于公开征求《影像型超声临床评价技术指导原则(征求意见稿)》意见的通知
胶体金免疫层析分析仪注册技术审查指导原则(2020年第14号)
抗甲状腺过氧化物酶抗体测定试剂注册技术审查指导原则(2020年第14号)
国家药监局关于发布胶体金免疫层析分析仪等7项注册技术审查指导原则的通告(2020年第14号)
促卵泡生成素检测试剂注册技术审查指导原则(2020年第14号)
总胆汁酸测定试剂注册技术审查指导原则(2020年第14号)
肌酐测定试剂注册技术审查指导原则(2020年第14号)
Bone Anchors - Premarket Notification (510(k)) Submissions: Guidance for Industry and Food and Drug Administration Staff
官方主题:Premarket, 510(k), Orthopedic
Product Recalls, Including Removals and Corrections: Guidance for Industry
官方主题:Recalls,
Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices: Guidance for Industry and Food and Drug Administration Staff
官方主题:CLIA (Clinical Laboratory Improvement Amendments)
Recommendations for Dual 510(k) and CLIA Waiver by Application Studies: Guidance for Industry and Food and Drug Administration Staff
官方主题:Premarket, Postmarket, CLIA (Clinical Laboratory Improvement Amendments), 510(k)
关于公开征求《X射线计算机体层摄影设备同品种临床评价技术指导原则(征求意见稿)》意见的通知
关于公开征求《同种异体植入性医疗器械病毒灭活工艺验证技术审查指导原则(2019年修订)(征求意见稿)》意见的通知
关于公开征求《医疗器械临床评价技术指导原则》意见的通知
国家药监局关于发布医疗器械通用名称命名指导原则的通告(2019年第99号)
Recommended Content and Format of Non-Clinical Bench Performance Testing Information in Premarket Submissions: Guidance for Industry and Food and Drug Administration Staff
官方主题:Premarket,
国家药监局关于发布医疗器械附条件批准上市指导原则的通告(2019年第93号)
医疗器械附条件批准上市指导原则(2019年第93号)
Bridging for Drug-Device and Biologic-Device Combination Products: Draft Guidance for Industry
官方主题:Combination Products
Real-Time Premarket Approval Application (PMA) Supplements: Guidance for Industry and FDA Staff
官方主题:Premarket, Administrative / Procedural, Device & Drug Safety, Premarket Approval (PMA)
30-Day Notices, 135-Day Premarket Approval (PMA) Supplements and 75-Day Humanitarian Device Exemption (HDE) Supplements for Manufacturing Method or Process Changes: Guidance for Industry and FDA Staff
官方主题:Premarket, Administrative / Procedural, Device & Drug Safety, HUD/HDE, Premarket Approval (PMA)
Annual Reports for Approved Premarket Approval Applications (PMA) : Guidance for Industry and Food and Drug Administration Staff
官方主题:Premarket, Administrative / Procedural, Device & Drug Safety, Premarket Approval (PMA)
Acceptance and Filing Reviews for Premarket Approval Applications (PMAs): Guidance for Industry and Food and Drug Administration Staff
官方主题:Premarket, Administrative / Procedural, Premarket Approval (PMA)